Personalizing Whole Genome Sequencing Doubles Diagnosis of Rare Diseases
Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases.
Read MorePosted by Andy Lundin | Nov 8, 2022 | Sequencing Systems |
Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases.
Read MorePosted by Andy Lundin | Nov 2, 2022 | Pancreatic |
Bluestar Genomics announced the results of a validation study for its early pancreatic cancer detection test.
Read MorePosted by Andy Lundin | Nov 1, 2022 | Pancreatic |
Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests.
Read MorePosted by Andy Lundin | Oct 27, 2022 | Covid 19, Research |
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Read MorePosted by Chris Wolski | Oct 7, 2022 | Quality Control Programs |
Multiple instruments as the core of testing provides a number of advantages and complexities for clinical laboratories.
Read More